EDGAR·FLOW

Ardent Health, Inc. — Form 8-K

Filed November 19, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
Ardent Health (market cap ~$324M) executed a secondary offering on 11/19/2026: selling shareholders EGI-AM Investments, L.L.C. and ALH Holdings, LLC sold 8,000,000 shares at $13.70/share ($109.6M gross), with underwriters J.P. Morgan and Barclays as co-leads. Company repurchases 1,500,000 shares from underwriters at same price (~$20.6M). Underwriters hold option for 1,200,000 additional shares. No proceeds to Ardent; pure secondary (selling shareholders liquidity).
Why this rating

Secondary offering dilutes existing holders ~2.5% (8M new shares), but no cash to company. Repurchase offsets dilution partially. Routine capital market event relative to company size.

View original filing on SEC.gov ↗ ARDT · stock on Yahoo Finance ↗

See more from November 19, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.